Abstract The development of new therapeutics and the validation of pathogenetic cancer mechanisms require representative laboratory models1,2. However, existing collections represent only a fraction of the diversity observed in human cancer2,3,4. Recent technologies have enabled efficient in vitro model derivation (for example, tumour organoids)5. However, whether these maintain essential properties of patient tumours during long-term expansion has not been systematically investigated.
William Hooper
As seen in:
Nature,
Wiley Online Library,
Science Magazine,
BioRxiv,
JD Supra,
F1000Research,
Cape May County Herald
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with William
Contact William, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack